Parkinson's disease. Second of two parts
- PMID: 9770561
- DOI: 10.1056/NEJM199810153391607
Parkinson's disease. Second of two parts
Abstract
At no time in the past have the basic and clinical sciences applied to Parkinson's disease been so active. Experimental therapies under study at present promise to improve on the limitations of existing treatments. Future progress in understanding the causation and pathogenesis of the disorder will permit the development of new treatments that will slow, halt, or even reverse the currently inexorable progressive course of Parkinson's disease.
Similar articles
-
Effective strategies in the management of Parkinson's disease.Hosp Med. 1998 Apr;59(4):287-90. Hosp Med. 1998. PMID: 9722367 Review.
-
Dopaminergic modulation of cognitive function-implications for L-DOPA treatment in Parkinson's disease.Neurosci Biobehav Rev. 2006;30(1):1-23. doi: 10.1016/j.neubiorev.2005.03.024. Epub 2005 Jun 1. Neurosci Biobehav Rev. 2006. PMID: 15935475 Review.
-
Levodopa therapeutics for Parkinson's disease: new developments.Parkinsonism Relat Disord. 2009 Jan;15 Suppl 1:S31-4. doi: 10.1016/S1353-8020(09)70009-4. Parkinsonism Relat Disord. 2009. PMID: 19131040 Review.
-
[Updates in practical neurology--I. The principles of modern levodopa therapy in Parkinson's disease].Ideggyogy Sz. 2007 Jan 20;60(1-2):61-4. Ideggyogy Sz. 2007. PMID: 17432097 Review. Hungarian.
-
[Pharmacological therapy of complicated Parkinson's disease].Rev Neurol. 1997 Aug;25 Suppl 2:S170-9. Rev Neurol. 1997. PMID: 9280685 Review. Spanish.
Cited by
-
Reward-related learning via multiple memory systems.Biol Psychiatry. 2012 Jul 15;72(2):134-41. doi: 10.1016/j.biopsych.2012.01.023. Epub 2012 Feb 24. Biol Psychiatry. 2012. PMID: 22365667 Free PMC article. Review.
-
Using point process models to describe rhythmic spiking in the subthalamic nucleus of Parkinson's patients.Annu Int Conf IEEE Eng Med Biol Soc. 2011;2011:757-60. doi: 10.1109/IEMBS.2011.6090173. Annu Int Conf IEEE Eng Med Biol Soc. 2011. PMID: 22254421 Free PMC article.
-
Vitiligo: a possible model of degenerative diseases.PLoS One. 2013;8(3):e59782. doi: 10.1371/journal.pone.0059782. Epub 2013 Mar 26. PLoS One. 2013. PMID: 23555779 Free PMC article.
-
Why do we need multifunctional neuroprotective and neurorestorative drugs for Parkinson's and Alzheimer's disorders?Rambam Maimonides Med J. 2010 Oct 31;1(2):e0011. doi: 10.5041/RMMJ.10011. Print 2010 Oct. Rambam Maimonides Med J. 2010. PMID: 23908783 Free PMC article.
-
Memory enhancement and deep-brain stimulation of the entorhinal area.N Engl J Med. 2012 Feb 9;366(6):502-10. doi: 10.1056/NEJMoa1107212. N Engl J Med. 2012. PMID: 22316444 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous